Jangada Mines completes drilling at Molly gold project in Brazil

Jangada completed 13 drill holes totaling 2,076m at the Molly Gold Project and expanded the program to ~2,480m (480m above initial plans); 44 samples have been sent with assays expected mid-April. The project holds a JORC inferred resource of 130,000 oz at 2 g/t (0.5 g/t cutoff) and historic high-grade intercepts cited; having met the 2,000m minimum, Jangada will exercise its option to acquire 100% of the 6,656.2-ha project for $100k cash plus $250k in shares, with vendor shares subject to a one-year lock-up and a retained 2.0% NSR. Mapping, geophysical and geochemical work is planned from May, with geophysics due by September 2026.

Analysis

This is a classic exploration-stage asymmetric bet: a small equity with binary geological outcomes but structural ceilings on upside from vendor economics and an expanded float. The more important second-order mechanic is cost-sensitivity — small Brazilian projects are disproportionately affected by energy and logistics swings (drilling, fuel, camp costs) which compress project NPV more than they do for tier-1 producers, so commodity-driven cost shocks can both raise gold realizations and simultaneously widen AISC, muting net value capture for juniors. Liquidity and market microstructure on AIM amplify moves: good assays can produce multi-bagger intraday gap-ups while negative or ambiguous labs produce outsized down-days because of low free float and retail concentration.

Strategically, the vendor-locked shares and any retained royalty materially cap marginal upside and make outright takeover economics less attractive to mid-cap consolidators; an acquirer would need to price-in the royalty and existing share issuance when modeling synergies. The roadmap of follow-up geophysics and trenching pushes meaningful de-risking into a multi-quarter timeline, which increases calendar risk and the chance that favorable macro moves (higher gold prices) are needed to justify capex. Jurisdiction and permitting friction in Pará remain non-trivial tail risks that lengthen the path to monetization and elevate the option value of near-term positive drill results rather than the asset's immediate intrinsic value.

The consensus mistake is treating a completed earn-in as de-risking the asset; it actually formalizes a capped, diluted exposure where upside is highly convex to one or two assay results while downside is limited by liquidity/dilution and commodity cycles. For portfolio construction, this should be traded as a catalyst-driven, size-constrained exploration punt with explicit hedges to the gold spot and energy cost exposures rather than as a buy-and-hold development story.

Key Decisions for Investors

• Speculative long JAN.L (AIM) — allocate no more than 0.25% NAV, enter on any post-assay weakness, place a tactical stop at -30%, target asymmetric exit at +200%-400% within 3-9 months if high-grade results are confirmed; downside limited by tiny float and dilution risk.
• Buy a protective hedge: go long GLD or IAU (0.5% NAV) for 3-12 months to capture a macro shock to gold that would lift junior valuations while offsetting idiosyncratic downside if assays disappoint.
• Structure a pair: long JAN.L (0.25% NAV) vs short 0.15% NAV in a diversified mid-cap gold producer (e.g., NEM) to isolate exploration idiosyncrasy; unwind within 6-12 months or on definitive resource upgrade.
• Options alternative (if liquid): buy 6–9 month call spread on JAN.L to cap premium outlay — max loss = premium, target 3x return if positive assays re-rate the story; avoid uncovered calls given share lock-up and low liquidity.